MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Search

Penumbra Inc

Fechado

SetorSaúde

350.36 12.31

Visão Geral

Variação de preço das ações

24h

Atual

Mín

312.23

Máximo

352

Indicadores-chave

By Trading Economics

Rendimento

581K

46M

Vendas

15M

355M

P/E

Médio do Setor

76.246

90.831

Margem de lucro

12.927

Funcionários

4,500

EBITDA

4M

55M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+13% upside

Dividendos

By Dow Jones

Próximos Ganhos

17 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

3.7B

13B

Abertura anterior

338.05

Fecho anterior

350.36

Sentimento de Notícias

By Acuity

21%

79%

31 / 361 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Penumbra Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de jan. de 2026, 13:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 de jan. de 2026, 12:35 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 de jan. de 2026, 12:29 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

15 de jan. de 2026, 14:37 UTC

Ações em Alta

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 de jan. de 2026, 13:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 de jan. de 2026, 12:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 de jan. de 2026, 12:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 de jan. de 2026, 12:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 de jan. de 2026, 12:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparação entre Pares

Variação de preço

Penumbra Inc Previsão

Preço-alvo

By TipRanks

13% parte superior

Previsão para 12 meses

Média 354.17 USD  13%

Máximo 388 USD

Mínimo 266 USD

Com base em 15 analistas de Wall Street que oferecem metas de preço de 12 meses para Penumbra Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

15 ratings

9

Comprar

6

Manter

0

Vender

Pontuação Técnica

By Trading Central

288.28 / 292.9394Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Weak Bullish Evidence

Sentimento

By Acuity

31 / 361 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat